Donor-Derived Cell-free DNA to DETect REjection in Cardiac Transplantation

Stopped Sponsor made decision to pause study while it was still in development phase. The FDA and IRB approval process had not been completed. No sites were activated. No subjects had been recruited for this study.

Conditions

• Heart Transplant Failure and Rejection

Interventions

• DIAGNOSTIC_TEST: Prospera Transplant Assessment
• PROCEDURE: Endomyocardial biopsy

Sponsor

Natera, Inc.